Category
Oncology
155 medicines
Antineoplastic and supportive medicines frequently subject to allocation, regional shortages, or complex sourcing.
97-144 of 155 in this category
- Letrozole RibociclibOncologyNot listed
- Leuprolide AcetateOncologyNot listed
- LomustineOncologyNot listed
- LorlatinibOncologyTo be discontinued
- MelphalanOncologyNot listed
- Melphalan HydrochlorideOncologyNot listed
- MercaptopurineOncologyNot listed
- MethotrexateOncologyTabletIn shortage
- Methotrexate SodiumOncologyIn shortage
- NelarabineOncologyNot listed
- NilotinibOncologyNot listed
- NiraparibOncologyNot listed
- OsimertinibOncologyNot listed
- OxaliplatinOncologyTo be discontinued
- PaclitaxelOncologyInjectionNot listed
- Paclitaxel Protein Bound ParticlesOncologyNot listed
- PacritinibOncologyNot listed
- PalbociclibOncologyTo be discontinued
- PemetrexedOncologyNot listed
- Pemetrexed DipotassiumOncologyNot listed
- Pemetrexed DisodiumOncologyTo be discontinued
- Pexidartinib HydrochlorideOncologyNot listed
- PirtobrutinibOncologyNot listed
- PomalidomideOncologyNot listed
- PralatrexateOncologyNot listed
- PralsetinibOncologyNot listed
- QuizartinibOncologyNot listed
- RegorafenibOncologyNot listed
- RepotrectinibOncologyNot listed
- RibociclibOncologyNot listed
- RipretinibOncologyNot listed
- RitlecitinibOncologyNot listed
- SelpercatinibOncologyNot listed
- SevabertinibOncologyNot listed
- SorafenibOncologyNot listed
- Sunitinib MalateOncologyNot listed
- TalazoparibOncologyNot listed
- TamoxifenOncologyNot listed
- Tamoxifen CitrateOncologyNot listed
- TemozolomideOncologyNot listed
- Tepotinib HydrochlorideOncologyNot listed
- ThalidomideOncologyNot listed
- ThioguanineOncologyNot listed
- ThiotepaOncologyNot listed
- TofacitinibOncologyNot listed
- TopotecanOncologyCapsuleNot listed
- Topotecan HydrochlorideOncologyNot listed
- TrametinibOncologyNot listed
Supply column: FDA drug shortage database - checked 20 Sept 2026